MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia with Lewy bodies (DLB)"

  • 2019 International Congress

    Dementia with Lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile

    S. Lerche, G. Machetanz, I. Wurster, B. Roeben, M. Zimmermann, A. Pilotto, A-K. Hauser, C. Schulte, I. Lachmann, T. Gasser, D. Berg, W. Maetzler, K. Brockmann (Tübingn, Germany)

    Objective: Whether GBA1 mutations are associated with a CSF alpha-synuclein profile in DLB. Background: Patients with dementia with Lewy bodies (DLB) reveal a variable pathology…
  • 2019 International Congress

    Impaired colour discrimination is associated with hallucinations in Dementia with Lewy Bodies

    E. Matar, K. Ehgoetz Martens, J. Phillips, G. Halliday, S. Lewis (Sydney, Australia)

    Objective: To explore the hypothesis that color discrimination impairment seen in Lewy body disorders is a specific biomarker of visual hallucinations rather than just overall…
  • 2019 International Congress

    The role of LRP10 mutations in Parkinson’s Disease and Dementia with Lewy Bodies

    A. Manini, E. Monfrini, L. Straniero, M. Vizziello, G. Franco, S. Duga, A. Di Fonzo (Milan, Italy)

    Objective: To test LRP10 in a cohort of Italian patients, with a clinical diagnosis of either Parkinson’s Disease (PD) (n=316) or Dementia with Lewy Bodies…
  • 2019 International Congress

    Differential temporal processing across Lewy body disorders and relation to cognitive fluctuations

    E. Matar, J. Phillips, K. Ehgoetz Martens, G. Halliday, S. Lewis (Sydney, Australia)

    Objective: To characterize differences in interval timing between patients with Parkinson’s disease and Dementia with Lewy bodies (DLB) and evaluate their relationship to cognitive fluctuations…
  • 2019 International Congress

    Restless Genital Syndrome in a patient with Dementia with Lewy Body

    M. Abu Al-Melh, M. Farghal, B. Al-Failakawii (Kuwait, Kuwait)

    Objective: To report the co-existence of Restless Genital Syndrome (RGS) and Dementia with Lewy Body (DLB), and to highlight the responsiveness to rotigotine (dopamine agonist)…
  • 2019 International Congress

    Is Dizziness a sign before DLB onset?

    M. Matsumura (Tokyo, Japan)

    Objective: I noticed that outpatients often continually complain about symptoms not found in PDD in DLB patients. In this time, I traced back the clinical…
  • 2019 International Congress

    A Study of Microglial Metabolism in Neuroinflammation

    T. Domenick, B. Cyr, R. Yost, M. Okun, V. Vedam-Mai (Gainesville, FL, USA)

    Objective: Targeting of microglial metabolism may be a potential therapeutic option for diseases such as PD [Parkinson’s Disease] and LBD [Lewy Body Dementia]. To establish…
  • 2019 International Congress

    Introduction of an Assessment Toolkit Increases the Rate of DLB Diagnosis

    A. Surendranathan, J. Kane, A. Bentley, S. Barker, J. Taylor, A. Thomas, I. Mckeith, D. Burn, J. O'Brien (Cambridge, United Kingdom)

    Objective: To assess whether diagnostic rates of both Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB) could be increased by the introduction of…
  • 2019 International Congress

    Diagnosing Dementia with Lewy Bodies – Characterizing the prevalence and underlying relationships between core and supportive clinical features

    E. Matar, K. Ehgoetz Martens, G. Halliday, S. Lewis (Sydney, Australia)

    Objective: To characterize the interrelationship between core and supportive features of Dementia with Lewy Bodies, and identify optimal methods for their detection to inform better…
  • 2019 International Congress

    Synaptic function in Parkinson’s disease associated with GBA mutations

    T. Eid, R. Bandopadhyay, T. Lashley, J. Hardy, J. Holton, T. Warner, P. Francis (London, United Kingdom)

    Objective: To investigate the pathological substrate of impaired cognition in Parkinson’s disease (PD) associated with glucocerebrosidase (GBA) mutation. Background: Mutations in glucocerebrosidase gene (GBA), originally…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 25
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley